The mechanism by which cortisol is produced in adrenal Gushing's syndrome,
when ACTH is suppressed, was previously unknown and was referred to as bein
g "autonomous." More recently, several investigators have shown that some c
ortisol and other steroid-producing adrenal tumors or hyperplasias are unde
r the control of ectopic (or aberrant, illicit, inappropriate) membrane hor
mone receptors. These include ectopic receptors for gastric inhibitory poly
peptide (GIP), beta -adrenergic agonists, or LH/hCG; a similar outcome can
result from altered activity of eutopic receptors, such as those for vasopr
essin (V1-AVPR), serotonin (5-HT4), or possibly leptin. The presence of abe
rrant receptors places adrenal cells under stimulation by a trophic factor
not negatively regulated by glucocorticoids, leading to increased steroidog
enesis and possibly to the proliferative phenotype. The molecular mechanism
s responsible for the abnormal expression and function of membrane hormone
receptors are still largely unknown. Identification of the presence of thes
e illicit receptors can eventually lead to new pharmacological therapies as
alternatives to adrenalectomy, now demonstrated by the long-term control o
f ectopic beta -AR- and LH/hCGR-dependent Gushing's syndrome by propanolol
and leuprolide acetate. Further studies will potentially identify a larger
diversity of hormone receptors capable of coupling to G proteins, adenylyl
cyclase, and steroidogenesis in functional adrenal tumors and probably in o
ther endocrine and nonendocrine tumors.